Patents Assigned to Westlake Laboratories, Inc.
  • Lipid-soluble thiamine derivatives in the treatment of autism
    Patent number: 6585996
    Abstract: The present invention is directed to a method for the treatment of autism comprising administering to a person in need of such treatment a therapeutically effective amount of a lipid-soluble thiamine derivative. The lipid-soluble thiamine derivative is preferably tetrahydrofurfuryl disulfide (TTFD). TTFD administration methods may include suppository forms, transdermal carriers, such as gels, lotions, or creams; and oral carriers, such as tablets or capsules.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: July 1, 2003
    Assignee: Westlake Laboratories, Inc.
    Inventors: Derrick Lonsdale, James P. Frackelton